WO2024241281 - MODIFIED VECTORS

National phase entry:
Publication Number WO/2024/241281
Publication Date 28.11.2024
International Application No. PCT/IB2024/055053
International Filing Date 24.05.2024
Title **
[English] MODIFIED VECTORS
[French] VECTEURS MODIFIÉS
Applicants **
CSL BEHRING L.L.C. 1020 First Avenue King of Prussia, Pennsylvania 19406-0901, US
SEATTLE CHILDREN’S HOSPITAL D/B/A SEATTLE CHILDREN’S RESEARCH INSTITUTE 1900 Ninth Avenue Seattle, Washington 98101, US
Inventors
AESCHIMANN, Florian c/o 655 Elizabeth Street Melbourne, Victoria 3000, AU
MONTELLESE, Christian c/o 655 Elizabeth Street Melbourne, Victoria 3000, AU
Priority Data
63/469,040   25.05.2023   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing2909
EPO Filing, Examination25590
Japan Filing590
South Korea Filing574
USA Filing, Examination13560
MasterCard Visa

Total: 43223

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] This disclosure relates generally to viral vectors useful for gene therapy applications. In particular the disclosure relates to lentiviral vectors, especially lentiviral vectors comprising modified insulator sequences.[French] La présente invention concerne de manière générale des vecteurs viraux utiles pour des applications de thérapie génique. En particulier, l'invention concerne des vecteurs lentiviraux, en particulier des vecteurs lentiviraux comprenant des séquences isolantes modifiées.
An unhandled error has occurred. Reload 🗙